• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Prediction tool for urinary tract infections in preverbal children

byJames EnglandandAnees Daud
April 23, 2018
in Emergency, Infectious Disease, Nephrology, Pediatrics, Urology
Reading Time: 2 mins read
Differences in sudden unexpected infant death rates reported between states
Share on FacebookShare on TwitterShare on LinkedIn

1. The study reports the development of a clinical and biochemical prediction tool for assessing the risk of urinary tract infection in preverbal children with fever. The model developed accurately predicted which patients may need further testing based on clinical variables, and who may need antibiotics therapy based on urine analysis supplement.

2. In a retrospective validation population, the clinical tool developed performed better than the diagnostic assessment algorithm recommended by the American Academy of Pediatrics.

Evidence Rating Level: 3 (Fair) 

Study Rundown: Evaluation of a fever in a pre-verbal infant remains a difficult clinical scenario for clinicians. Urinary tract infection (UTI) is a common cause of fever in this population, representing up to 7% of cases. Diagnostic algorithms have previously been developed and recommended by the American Academy of Pediatrics, but populations used to validate these tools have been small and many clinicians do not adhere to them. The current study sought to develop prediction models to aid clinicians in deciding who may need further work up for UTI based on clinical features, and in conjunction with quickly obtained analysis of the urine (biochemical dipstick, microscopic analysis), decisions on upfront antibiotic treatment. The developed tool performed better than the AAP recommended algorithm in the validation population. Use of the tool is also predicted to reduce the delay-to-treatment for those who would otherwise wait for urine culture results.

The main strengths of the study included the large population both for development and validation of the tool. The main limitations of the study were the single center design, which limits generalizability.

Click to read the study, published in JAMA Pediatrics

RELATED REPORTS

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

Relevant Reading: Accuracy of the Urinalysis for Urinary Tract Infections in Febrile Infants 60 Days and Younger

In-Depth [case-control study]: This study used a consecutive retrospective population of children aged 2 months to 2 years with a fever of 38°C who presented to Children’s Hospital of Pittsburgh between Jan. 2007 and April 2013. Patients with confirmed UTI (based on positive culture of at least 50 000 CFU/mL, along with pyuria based on WBC count or positive leukocyte esterase) and a randomly selected population without UTI were included in a nested case-control design for the development of the prediction tools. The developed algorithm used 5 models: one with only clinical features and four with clinical and biochemical/cytologic data. A secondary database was created to validate the prediction tool.

The training database used for the development of the model included 1686 children, while the validation database had 384 children. Compared to the AAP algorithm, the developed prediction tool had greater sensitivity, missing fewer cases of UTI, while also reducing unnecessary testing by 8.1%. Compared to a method of treated all those with leukocyte esterase result of ≥1+, the designed tool reduced the delay to therapy by 10.6%(95%CI, 0.9%-20.4%).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: urinary tract infection in children
Previous Post

Teens’ e-cigarette use independently linked to future marijuana use

Next Post

Smartphone medication adherence application did not improve systolic blood pressure

RelatedReports

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk
Infectious Disease

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

June 8, 2015
Next Post
Prevalence of hypertension among adolescents varies by race and BMI

Smartphone medication adherence application did not improve systolic blood pressure

2 Minute Medicine Rewind April 23, 2018

Trends in US counties cause-specific mortality rates

Rustbelt states may have greatest racial disparities between black and white men for firearm homicides

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.